Related Experiment Video

Updated: Jun 3, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice

Jorge M Blando1, Steve Carbajal, Erika Abel

  • 1Division of Pharmacology and Toxicology, The University of Texas at Austin, Austin, TX, USA.

Neoplasia (New York, N.Y.)
|March 11, 2011
PubMed

Insights

We developed a new mouse model for prostate cancer by activating signal transducer and activator of transcription 3 (Stat3) and reducing PTEN. This model shows accelerated tumor development and progression, aiding prostate cancer research.

Area of Science:

  • * Oncology
  • * Molecular Biology
  • * Genetics

Background:

  • * Signal transducer and activator of transcription 3 (Stat3) is crucial in cell growth and survival.
  • * PTEN loss is common in human cancers, including prostate cancer.
  • * Understanding Stat3 and PTEN interactions is key to developing new cancer therapies.

Purpose of the Study:

  • * To create a novel transgenic mouse model for prostate cancer research.
  • * To investigate the role of Stat3 and PTEN in prostate cancer development and progression.
  • * To analyze the molecular mechanisms underlying prostate cancer in this model.

Main Methods:

  • * Developed a transgenic mouse model (ARR(2)Pb.Stat3C) expressing constitutively active Stat3 under a prostate-specific promoter.
  • * Crossed ARR(2)Pb.Stat3C mice with PTEN(+/-) mice to examine combined effects.
  • * Analyzed prostate tissues for hyperplasia, PIN, adenocarcinoma, and molecular markers (phospho-Stat3, phospho-Akt, NF-κB, cyclin D1, Ki67, β-catenin, E-cadherin).

Main Results:

  • * ARR(2)Pb.Stat3C mice showed hyperplasia and PIN but no adenocarcinoma.
  • * Combined loss of PTEN and Stat3 activation in ARR(2)Pb.Stat3C x PTEN(+/-) mice led to rapid adenocarcinoma development (61% incidence by 12 months).
  • * Upregulation of phospho-Stat3, phospho-Akt, phospho-NF-κB, cyclin D1, and Ki67, with reduced β-catenin and E-cadherin, observed in tumors.

Conclusions:

  • * Stat3 and Akt signaling pathways cooperate in prostate cancer development and progression.
  • * The ARR(2)Pb.Stat3C x PTEN(+/-) mouse model effectively recapitulates key features of human prostate cancer.
  • * This model provides a valuable tool for studying Stat3 and Akt signaling in prostate cancer and for evaluating therapeutic strategies.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...